Open Orphan
Dublin
About Open Orphan
Open Orphan Open Orphan is a rapidly growing niche CRO pharmaceutical services group which is a world leader in the testing of vaccines and antivirals through the use of human challenge clinical trials. Conducted from Europe's only 24-bedroom quarantine clinic with onsite virology providing individually isolated rooms and connected to our specialist laboratory facility. Which offers highly specialised virology and immunology laboratory services to support pre-clinical and clinical respiratory drug, antiviral, and vaccine discovery and development.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 101 – 250
- Estimated revenue: $10K – $50K
- Total funding: $7.0M
- Funding stage: IPO
- Last round: Post-IPO Equity (Feb 2020)
- Ticker: lse:ORPH
- Website: openorphan.com
- Phone: +353 (01) 6440007
Industries & Categories
Life Science, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/open-orphan-2243705 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.